ClinicalTrials.Veeva

Menu

Are the Pancreatic Serum Proteins Pancreatic Stone Protein (PSP) and Pancreatitis-Associated Protein (PAP) Predictive for the Development of Sepsis? Retrospective Study in Trauma Patients With Soft Tissue Defects.

University of Zurich (UZH) logo

University of Zurich (UZH)

Status

Unknown

Conditions

Trauma Patients With Soft Tissue Defects

Treatments

Procedure: retrospective Observation

Study type

Observational

Funder types

Other

Identifiers

NCT00564109
StV 10-2003

Details and patient eligibility

About

Retrospective analysis of PSP- and PAP-serum levels in trauma patients with soft tissue defects and possible correlation with the incidence and onset of infection and sepsis.

Enrollment

15 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Trauma patients submitted to the university hospital Zurich, aged 18-65 with soft tissue defects

Exclusion criteria

  • Patients with known immunocompromising illnesses, drug abuse or infectious diseases.

Trial contacts and locations

1

Loading...

Central trial contact

01 Studienregister MasterAdmins

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems